Minocycline in Severe Cerebral Amyloid Angiopathy: A Single‐Center Cohort Study

Minocycline in Severe Cerebral Amyloid Angiopathy: A Single‐Center Cohort Study

Background Evidence from animal studies suggests that minocycline may reduce lobar intracerebral hemorrhage (ICH) recurrence in cerebral amyloid angiopathy, possibly by inhibiting perivascular extracellular matrix degradation in cerebral small vessels. There is currently no evidence of its safety or...

Full description

Bibliographic Details
Main Authors: Francesco Bax, Andrew Warren, Avia Abramovitz Fouks, Hilde van den Brink, Susanne J. van Veluw, Mariel G. Kozberg, Steven M. Greenberg
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cerebral amyloid angiopathy
intracerebral hemorrhage
matrix metalloproteinases
minocycline
preliminary study
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.033464

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.033464

Similar Items